𝔖 Bobbio Scriptorium

✦ LIBER ✦

TCT-426 Our Experience With Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in All Comers with Coronary Artery Disease -"Real Absorb Registry".

✍ Scribed by Seth, Ashok; Ravisekar, Vinayak; Rastogi, Vishal; Kumar, Vijay; Kaul, Upendra; Mathur, Atul; Agarwal, Praveer; Sanghi, Vinay

Book ID: 122203898
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 60 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.1167

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-35 Evaluation of the Absorb Everolim

TCT-35 Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

✍ Peter Smits 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

EVALUATION OF THE ABSORB EVEROLIMUS ELUT

EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIAL

✍ Dariusz Dudek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

TCT-32 First Report of the Four Year Cli

TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

✍ Chevalier, Bernard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

THE ABSORB TRIAL: EVALUATION OF THE ABSO

THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT B

✍ Christiansen, Evald Hoej 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 181 KB

FIRST REPORT OF THE THREE YEAR CLINICAL

FIRST REPORT OF THE THREE YEAR CLINICAL AND MULTI–MODALITY IMAGING RESULTS OF THE ABSORB TRIAL EVALUATING THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS

✍ Serruys, Patrick 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 158 KB

TCT-37: ABSORB Cohort B Trial: 9 Months

TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB